Almici C - Search Results

1

Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.

Carlo-Stella C, Mangoni L, Almici C, Frassoni F, Fiers W, Rizzoli V. Carlo-Stella C, et al. Among authors: almici c. Leukemia. 1990 Aug;4(8):561-6. Leukemia. 1990. PMID: 1697011

2

Counterflow centrifugal elutriation: experimental and clinical applications.

Almici C, Donnenberg AD, Rizzoli V. Almici C, et al. J Hematother. 1992 Fall;1(3):279-88. doi: 10.1089/scd.1.1992.1.279. J Hematother. 1992. PMID: 1365034 Review.

3

Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow.

Carlo-Stella C, Mangoni L, Almici C, Cottafavi L, Meloni G, Mandelli F, Rizzoli V. Carlo-Stella C, et al. Among authors: almici c. Blood. 1992 Nov 1;80(9):2412-8. Blood. 1992. PMID: 1421413 Free article. Clinical Trial.

4

Autologous bone marrow transplantation for acute myeloid and lymphoid leukemia.

Rizzoli V, Carlo-Stella C, Almici C, Garau D, Carella AM, Coser P, Angrilli F, Bernabei PA, Mozzana R, Alessandrino E, et al. Rizzoli V, et al. Among authors: almici c. Leukemia. 1992 Nov;6 Suppl 4:103-5. Leukemia. 1992. PMID: 1434811 Clinical Trial. No abstract available.

5

Purging the bone marrow in non-Hodgkin's lymphomas. Is there any evidence of its value?

Rizzoli V, Carlo-Stella C, Almici C, Caramatti C, Mangoni L. Rizzoli V, et al. Among authors: almici c. Leuk Lymphoma. 1992;7 Suppl:7-10. doi: 10.3109/10428199209061556. Leuk Lymphoma. 1992. PMID: 1493461 No abstract available.

6

Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.

Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V. Carlo-Stella C, et al. Among authors: almici c. Exp Hematol. 1992 Mar;20(3):328-33. Exp Hematol. 1992. PMID: 1568448

7

In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.

Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V. Carlo-Stella C, et al. Among authors: almici c. Bone Marrow Transplant. 1991 Oct;8(4):265-73. Bone Marrow Transplant. 1991. PMID: 1756324

8

Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF) in patients with lymphoid malignancies receiving unpurged or mafosfamide-purged autografts.

Carlo-Stella C, Mangoni L, Almici C, Meloni G, Mandelli F, Rizzoli V. Carlo-Stella C, et al. Among authors: almici c. Behring Inst Mitt. 1991 Dec;(90):69-74. Behring Inst Mitt. 1991. PMID: 1801693 Clinical Trial. No abstract available.

9

The problem of purging for ABMT in non-Hodgkin's lymphoma.

Rizzoli V, Carlo-Stella C, Almici C, Caramatti C, Mangoni L. Rizzoli V, et al. Among authors: almici c. Leukemia. 1991;5 Suppl 1:63-7. Leukemia. 1991. PMID: 1890869 No abstract available.

10

Human peripheral blood mononuclear cell subfractionation using counterflow centrifugation elutriation.

Almici C, Mangoni L, Carlo-Stella C, Rizzoli V. Almici C, et al. Haematologica. 1991 Mar-Apr;76(2):89-93. Haematologica. 1991. PMID: 1937178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters